www.ngram.com Open in urlscan Pro
76.76.21.61  Public Scan

Form analysis
0 forms found in the DOM

Text Content

LIFE SCIENCES DATA.
NOW CONNECTED AND CONVERSABLE.

From drug discovery to commercialization – dive deep into a universe of curated
datasets. Streamline market research and sharpen your competitive edge, all
through intuitive AI-driven conversations.

Try For Free



Request a dataset



Search for Data on

Companies

Drugs

Molecules

Indications

KOLS

Clinical Trials

Data across many datasets

PubMed

Clinical Trials

News

SEC Filings

Press Releases

Soon

Conferences

Soon

Company Websites

Soon

What companies are doing clinical trials on GLP-1?


Clinical Trials Arena

Obesity: Six trials to watch over the next 12 months

ClinicalTrials.gov

GLP-1 receptor agonists: an updated review of head-to

Routers

Lilly experimental 'triple G' obesity drug leads to 24.2%

ngram

-

10:23pm

Companies conducting GLP-1 based clinical trials:




 1. Novo Nordisk - The Danish company has been conducting trials for their oral
    drug candidate, semaglutide (also marketed under the name Rybelsus for
    type-2 diabetes treatment).

 2. Eli Lilly - They offered fresh data about their drug candidate orforglipron.

 3. Pfizer - They are nearing the completion of trials for their drug
    danuglipron tromethamine, a pipeline drug that also targets GLP-1 receptors.
    This medication is being examined for its efficacy and safety in both
    obesity and type 2 diabetes contexts.

 4. Altimmune - The company is close to finishing a Phase II trial testing the
    efficacy and safety of pemvidutide, a dual agonist targeting GLP-1 and
    glucagon receptors (GCGR).

 5. Innovent Biologics - The China-based company is conducting trials for their
    dual agonist drug candidate mazdutide, which targets GLP-1 and GCGR as well.
    Their Phase III trial is set to conclude in 2024.

Built by talking to the best in the industry

 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 


CURATED & CONNECTED DATASETS:
AI-CREATED, HUMAN-AUGMENTED

Connect vast array of datasets spanning clinical trials to PubMed articles under
one roof. Easily pull data from disparate sources, eliminating the need for
multiple expensive subscriptions. With AI-driven data creation and meticulous
human curation, ensure thoroughness and accuracy in every piece of information
you access.


CURRENT DATASET COVERAGE:

PubMed

ClinicalTrials.gov

SEC Financial Filings

News Articles

Press Releases

Partial

Conferences

Partial


COMING SOON:

PubChem

OpenFDA

PatentScope

Research Journals

BioGRID

KEGG

OpenPayments

NMPA(China)

OpenTargets

WHO Datasets

Don't see a dataset you're looking for? Let us know.

Request a Dataset



Adopt the Power of AI for Your Research Needs


UNPARALLELED INTELLIGENCE AT YOUR FINGERTIPS

With Ngram, your quest for comprehensive and timely research is simplified.
Powered by AI, Ngram turns complex data from various sources into digestible
insights for your company. All you need is to ask in simple English. The era of
tiresome manual research is over, welcome to the future of informed decision
making with Ngram.


AI-POWERED RESEARCH ASSISTANT

Ngram uses AI agents to scan multiple data sources and analyze complex datasets
to extract key insights, saving you and your teams hours of analysis work.


SIMPLE QUERIES, POWERFUL ANSWERS

Ask your questions in simple English and receive comprehensive, source cited
answers. Transform the way you understand and utilize competitive analysis data.

What companies are doing clinical trials on GLP-1?



TIMELY AND COMPREHENSIVE DATA

Ngram uses AI agents to scan multiple data sources and analyze complex datasets
to extract key insights, saving you and your teams hours of analysis work.


BUILT BY LISTENING TO THE EXPERTS

We listened to the top minds in the Pharma Industry, and built Ngram to be their
ideal research partner.

Research Librarian


MICHAEL ZU

Sorting through countless websites and PRs is now obsolete. I can receive
all-encompassing and integrated responses to intricate questions using just one
query. It has revolutionized our research productivity.

Business Development


RACHEL MCKAY

Our team has become significantly more efficient, turning disparate data into
actionable insights in a snap, making strategic decision-making faster and more
informed than ever before.

CI Analyst


ANDY LONG

What used to be a tedious process of connecting disjointed data sources, is now
a simplified one-step procedure. It's as if I have a professional research
assistant who knows exactly where to look!


SIMPLE PRICING FOR COMPLETE ANALYSIS

Personal

Simple Questions

Basic Datasets

No Analytics

Basic Charts

No Chat History

No Chart Sharing

No Reports

Try Now



Professional (coming soon)

Complex Questions

Premium Datasets

Analytics

Chart Customizations

Chat History

Chat Sharing

AI drafted Research Reports

Coming Soon




FAQ

What types of data sources can Ngram pull from?



Can Ngram interpret and answer complex inquiries with technical pharma language
and jargon?



Is there a limit to the number of inquiries or data extraction volume I can make
in a day?



Can I see a demo of the product before I decide to purchase?



Can I change or cancel my subscription plan anytime?


READY TO AMP UP YOUR COMPETITIVE INTELLIGENCE?

Try it for free and experience a new era of Pharma competitive intelligence to
keep ahead of others.

Try Now For Free


 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 


COMPANY

Linkedin

Careers

About


RESOURCES

Blog

Privacy Policy

Sitemap



© 2024 Ngram. All rights reserved

MedChat

Datasets

Features

Pricing

Alerts



Talk to Founders

Sign Up